SUBSCRIBE
SUBSCRIBE
News   Deals

Genentech, Inc. (JOBS) Gives Long-Term Forecast to Fend off Roche (JOBS)

March 2, 2009 | 
1 min read
NEW YORK, March 2 (Reuters) - Genentech Inc (DNA.N) provided investors with earnings and revenue growth projections for every year through 2018 as it aimed to demonstrate that the company is worth more than Roche is willing to pay for it.
Mergers & acquisitions
Genentech, Inc. Roche
MORE ON THIS TOPIC
Bayer office in Basel, Switzerland
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
August 12, 2025
 · 
2 min read
 · 
Tristan Manalac
A contemporary art collage depicting a giant ear listening to a message bubble while covering it with a hand. The concept of taking in a useful experience or overhearing a new idea.
Mergers & acquisitions
Novartis Continues Hunt for New Assets With Rumored Takeover of RNA Specialist Avidity
August 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Businessmans hand holding a red globe with the map of China, symbolizing international business, trade, global markets, global influence, economics, or Chinese business ventures
China
Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive
August 6, 2025
 · 
7 min read
 · 
Leslie Zhen Liang
Human brain with abstract visualization of neuron activity
Brain Cancer
Glioblastoma Funding Rises as Nonprofits Drive Interest and Pharma Returns to the Table
August 4, 2025
 · 
6 min read
 · 
Ben Hargreaves